{"title":"Test urine Drugdiag® Cassette","description":"\u003csection class=\"ama-collection-description\"\u003e\n \u003ch2\u003eTest urinari Drugdiag® cassette per il rilevamento di droghe\u003c\/h2\u003e\n\n \u003cp\u003e\n I \u003cstrong\u003etest urinari Drugdiag® cassette\u003c\/strong\u003e proposti da \u003cstrong\u003eAMA Prévention\u003c\/strong\u003e\n permettono di effettuare un \u003cstrong\u003erilevamento urinario di droghe\u003c\/strong\u003e semplice, rapido e leggibile.\n Questo formato è adatto alle esigenze di \u003cstrong\u003eaziende\u003c\/strong\u003e, \u003cstrong\u003eprofessionisti della salute\u003c\/strong\u003e,\n \u003cstrong\u003estrutture di prevenzione\u003c\/strong\u003e, \u003cstrong\u003eenti locali\u003c\/strong\u003e e \u003cstrong\u003eprivati\u003c\/strong\u003e\n che cercano una soluzione affidabile per rilevare diverse famiglie di sostanze psicoattive.\n \u003c\/p\u003e\n\n \u003cp\u003e\n A seconda dei modelli, i test urinari Drugdiag® cassette possono rilevare\n \u003cstrong\u003eTHC\u003c\/strong\u003e, \u003cstrong\u003ecocaina\u003c\/strong\u003e, \u003cstrong\u003eoppioidi\u003c\/strong\u003e,\n \u003cstrong\u003eanfetamine\u003c\/strong\u003e, \u003cstrong\u003emetanfetamine\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e,\n \u003cstrong\u003ebenzodiazepine\u003c\/strong\u003e, \u003cstrong\u003emetadone\u003c\/strong\u003e, \u003cstrong\u003ebupenorfina\u003c\/strong\u003e,\n \u003cstrong\u003ebarbiturici\u003c\/strong\u003e o \u003cstrong\u003eantidepressivi triciclici\u003c\/strong\u003e,\n a seconda della referenza scelta.\n \u003c\/p\u003e\n\n \u003ch3\u003eDrugdiag® cassette: un formato preciso, leggibile e pratico\u003c\/h3\u003e\n\n \u003cp\u003e\n Il \u003cstrong\u003etest urinario Drugdiag® cassette\u003c\/strong\u003e si utilizza dopo il prelievo di un campione di urina.\n Basta depositare alcune gocce nelle cavità del test usando la pipetta fornita.\n Le strisce reattive mostrano quindi un risultato visivo in pochi minuti, con una lettura chiara\n direttamente sul dispositivo.\n \u003c\/p\u003e\n\n \u003cp\u003e\n Questo formato cassette è particolarmente apprezzato per la sua \u003cstrong\u003esemplicità d’uso\u003c\/strong\u003e,\n il \u003cstrong\u003ecosto contenuto\u003c\/strong\u003e e la capacità di rilevare più sostanze a seconda del modello.\n Alcune referenze permettono un rilevamento multi-droga fino a \u003cstrong\u003e11 sostanze simultaneamente\u003c\/strong\u003e,\n rendendolo una soluzione adatta a campagne di prevenzione, esigenze professionali e controlli occasionali.\n \u003c\/p\u003e\n\n \u003ch3\u003eUna gamma sviluppata da un produttore francese specializzato\u003c\/h3\u003e\n\n \u003cp\u003e\n I test urinari Drugdiag® sono sviluppati da \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, produttore francese specializzato\n in test diagnostici rapidi. AMA Prévention seleziona questi dispositivi per la loro leggibilità,\n facilità di utilizzo e adattamento agli usi professionali e privati.\n \u003c\/p\u003e\n\n \u003cp\u003e\n A seconda delle referenze, alcuni test possono beneficiare di caratteristiche o menzioni specifiche,\n tra cui il \u003cstrong\u003emarchio CE\u003c\/strong\u003e, una produzione regolamentata secondo standard di qualità applicabili,\n il \u003cstrong\u003elabel Alsace Cœur\u003c\/strong\u003e o la menzione \u003cstrong\u003eUtilizzato dalle Forze Armate Francesi\u003c\/strong\u003e\n quando applicabile al prodotto selezionato.\n \u003c\/p\u003e\n\n \u003ch3\u003eTest urinari per aziende, salute, prevenzione e uso privato\u003c\/h3\u003e\n\n \u003cp\u003e\n I \u003cstrong\u003etest urinari di rilevamento\u003c\/strong\u003e sono utilizzati in molti contesti:\n prevenzione aziendale, auto-controllo, recupero patente, supporto in strutture sanitarie,\n azioni di sensibilizzazione, monitoraggio interno o necessità occasionale di verifica.\n Sono test rapidi di orientamento, utili per ottenere una prima indicazione.\n \u003c\/p\u003e\n\n \u003cp\u003e\n In ambito professionale, l’uso di test di rilevamento deve inserirsi in un quadro chiaro,\n proporzionato e conforme alle norme applicabili, soprattutto quando le posizioni interessate presentano\n un rischio particolare per la sicurezza delle persone. AMA Prévention supporta le aziende\n nella scelta delle referenze più adatte alle loro esigenze.\n \u003c\/p\u003e\n\n \u003ch3\u003eOrdina i tuoi test urinari Drugdiag® cassette\u003c\/h3\u003e\n\n \u003cp\u003e\n Ordina i tuoi \u003cstrong\u003etest urinari Drugdiag® cassette\u003c\/strong\u003e, \u003cstrong\u003etest urinari THC\u003c\/strong\u003e,\n \u003cstrong\u003etest urinari multi-droga\u003c\/strong\u003e e dispositivi di rilevamento professionale direttamente\n online su AMA Prévention. Spedizione rapida in 24h con DPD, servizio clienti reattivo\n e supporto professionale per scegliere il test più adatto alla tua situazione.\n \u003c\/p\u003e\n\n \u003cp\u003e\n \u003cstrong\u003e\n Per ordini in volume, esigenze professionali o campagne di prevenzione,\n \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\"\u003erichiedi un preventivo personalizzato a AMA Prévention\u003c\/a\u003e.\n \u003c\/strong\u003e\n \u003c\/p\u003e\n\u003c\/section\u003e","products":[{"product_id":"test-urinaire-cassette-6-drogues","title":"Test Urinario 6 droghe Drugdiag® 6","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 6 urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e\n \u003cspan class=\"ama-bsafe-kicker\"\u003eTest urinario 6 droghe\u003c\/span\u003e\n \n \u003ch2 class=\"ama-bsafe-title\"\u003e\n Drugdiag® 6: test urinario multi-droghe professionale\n \u003c\/h2\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Il \u003cstrong\u003etest urinario Drugdiag® 6 droghe\u003c\/strong\u003e è un dispositivo di screening affidabile, preciso e conforme ai requisiti medici. Progettato dal laboratorio francese \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, n.1 nel test diagnostico rapido, consente la rilevazione simultanea di \u003cstrong\u003e6 famiglie di sostanze psicoattive\u003c\/strong\u003e nelle urine.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Ricerca le seguenti famiglie: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e cannabis, \u003cstrong\u003eCOC\u003c\/strong\u003e cocaina, \u003cstrong\u003eAMP\u003c\/strong\u003e amfetamine, \u003cstrong\u003eMET\u003c\/strong\u003e metanfetamine, \u003cstrong\u003eMOP\u003c\/strong\u003e oppiacei e \u003cstrong\u003eBUP\u003c\/strong\u003e buprenorfina.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Raccomandato per uso professionale, medico, istituzionale o personale, si integra in un approccio di prevenzione strutturata: datori di lavoro, medicina del lavoro, strutture sanitarie, monitoraggio delle dipendenze, posti sensibili e auto-controllo responsabile.\n \u003c\/p\u003e\n \n \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eRilevazione simultanea di 6 famiglie\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eFormato urinario a lettura rapida\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eUso sanitario, aziendale e auto-controllo\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eRilevazione\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003e6 famiglie mirate\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eSostanze rilevate\u003c\/h2\u003e\n\n \u003cp\u003e\n Il test urinario Drugdiag® 6 rileva le 6 famiglie di sostanze psicoattive più frequentemente riscontrate nella pratica professionale, clinica e preventiva.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis:\u003c\/strong\u003e metabolita urinario del THC, associato al consumo di cannabis, resina, fiori o prodotti contenenti THC.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaina:\u003c\/strong\u003e cocaina, crack e metaboliti correlati rilevabili nelle urine.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAmfetamine:\u003c\/strong\u003e stimolanti di tipo amfetaminico, speed e sostanze correlate.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetamine:\u003c\/strong\u003e crystal meth, ice e derivati correlati.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOppiacei:\u003c\/strong\u003e morfina, eroina, oppio e composti correlati.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorfina:\u003c\/strong\u003e molecola utilizzata soprattutto in alcuni trattamenti sostitutivi degli oppiacei.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e10 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n Le soglie devono essere interpretate secondo il foglio illustrativo del produttore, il contesto clinico o professionale e gli obiettivi di screening. Un risultato positivo rapido rimane un risultato preliminare.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUtilizzi\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eAzienda, salute, monitoraggio\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePrincipali utilizzi\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003ePrevenzione in azienda\u003c\/h3\u003e\n \u003cp\u003e\n Conforme allo spirito dell’articolo \u003cstrong\u003eL.4121-1 del Codice del lavoro\u003c\/strong\u003e, questo test può integrarsi in un percorso di prevenzione dei rischi nei posti di sicurezza e protezione: conduzione di mezzi, trasporti, edilizia, industria, sicurezza privata o settori sensibili.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eUso medico e in ambito delle dipendenze\u003c\/h3\u003e\n \u003cp\u003e\n Il test urinario Drugdiag® 6 è pertinente per i professionisti della salute: monitoraggio del trattamento, consulenza in dipendenze, controllo dei consumi e monitoraggio dei trattamenti sostitutivi degli oppiacei grazie al pannello \u003cstrong\u003eBUP\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eAuto-controllo personale\u003c\/h3\u003e\n \u003cp\u003e\n Può essere utilizzato in auto-controllo prima di una scadenza importante, una visita medica, una ripresa di un posto sensibile o nell’ambito di un percorso personale di riduzione o cessazione del consumo.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003eVantaggi del test Drugdiag® 6\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eScreening simultaneo:\u003c\/strong\u003e 6 famiglie di sostanze ricercate in un’unica analisi.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eCopertura estesa:\u003c\/strong\u003e cannabis, cocaina, amfetamine, metamfetamine, oppiacei e buprenorfina.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eRisultato rapido:\u003c\/strong\u003e lettura visiva semplice in pochi minuti secondo le istruzioni.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eProduttore francese:\u003c\/strong\u003e dispositivo della gamma Drugdiag® del laboratorio Toda Pharma.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQualità professionale:\u003c\/strong\u003e certificazione CE e sistema qualità ISO 13485.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eAdatto al Piano Joana:\u003c\/strong\u003e pertinente per le iniziative di prevenzione in azienda e la messa in sicurezza dei posti sensibili.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eUso polivalente:\u003c\/strong\u003e salute, azienda, istituzioni e auto-controllo personale.\u003c\/li\u003e\n \u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eRisultati\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eDurate urinarie\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eDurate di rilevazione urinaria\u003c\/h2\u003e\n\n \u003cp\u003e\n La durata della rilevazione nelle urine dipende da molti fattori: frequenza e quantità di consumo, metabolismo, idratazione, funzione renale, anzianità dell’uso e potenza dei prodotti consumati.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis:\u003c\/strong\u003e durata indicativa variabile da 1 a 30 giorni a seconda del profilo di consumo.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 30 giorni\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaina:\u003c\/strong\u003e rilevazione urinaria indicativa generalmente compresa tra 1 e 4 giorni.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 giorni\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAmfetamine:\u003c\/strong\u003e rilevazione urinaria indicativa generalmente compresa tra 1 e 4 giorni.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 giorni\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetamfetamine:\u003c\/strong\u003e rilevazione urinaria indicativa generalmente compresa tra 1 e 4 giorni.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 giorni\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOppiacei:\u003c\/strong\u003e rilevazione urinaria indicativa generalmente compresa tra 1 e 4 giorni.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 giorni\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorfina :\u003c\/strong\u003e durata indicativa di rilevamento generalmente compresa tra 1 e 7 giorni.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 giorni\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n Queste durate sono indicative. Possono variare notevolmente in base al metabolismo, indice di massa corporea, funzione renale, frequenza d’uso, trattamenti seguiti e concentrazione dei prodotti consumati.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eRisultato negativo\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Un risultato negativo indica che le sostanze ricercate non sono state rilevate oltre le soglie di rilevamento del test. Ciò non garantisce un’assenza assoluta di qualsiasi sostanza.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eRisultato positivo\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Un risultato positivo indica una reazione compatibile con la presenza di una o più famiglie ricercate nelle urine. Per qualsiasi contesto ufficiale, professionale, medico o contestato, può essere necessaria una conferma in laboratorio.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eRisultato non valido\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Un risultato non valido può essere dovuto a una cattiva manipolazione, un volume insufficiente di campione o il mancato rispetto del tempo di lettura. In tal caso, è necessario ripetere il test con un nuovo dispositivo.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTecnica\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQualità e affidabilità\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eCompetenza tecnica\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eTecnologia a oro colloidale\u003c\/h3\u003e\n \u003cp\u003e\n Il dispositivo utilizza l’immunocromatografia a competizione con anticorpi marcati con oro colloidale, permettendo una lettura chiara, rapida e adatta agli usi professionali.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eAffidabilità GC\/MS\u003c\/h3\u003e\n \u003cp\u003e\n La precisione di questo dispositivo di screening urinario professionale è stata confrontata con il metodo di riferimento di laboratorio, la cromatografia in fase gassosa accoppiata alla spettrometria di massa (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e).\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eConformità qualità\u003c\/h3\u003e\n \u003cp\u003e\n Progettato dal laboratorio francese Toda Pharma, questo dispositivo medico diagnostico \u003ci\u003ein vitro\u003c\/i\u003e è certificato \u003cstrong\u003eCE\u003c\/strong\u003e e conforme alla norma di qualità \u003cstrong\u003eISO 13485\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003eCaratteristiche principali\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eTipo di test :\u003c\/strong\u003e test urinario multi-droga a lettura rapida.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSostanze ricercate :\u003c\/strong\u003e THC-COOH, COC, AMP, MET, MOP, BUP.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFormato :\u003c\/strong\u003e dispositivo urinario professionale a lettura visiva.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eUso :\u003c\/strong\u003e prevenzione professionale, salute, monitoraggio delle dipendenze, auto-controllo.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eProduttore :\u003c\/strong\u003e laboratorio francese Toda Pharma, n°1 nel test di diagnosi rapida.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQualità:\u003c\/strong\u003e dispositivo medico diagnostico in vitro con marcatura CE e ISO 13485.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003ch3\u003eAssenza di reazioni crociate\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eFarmaci comuni:\u003c\/strong\u003e aspirina, ibuprofene, paracetamolo, amoxicillina, penicillina, destrometorfano.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSostanze fisiologiche e alimentari:\u003c\/strong\u003e caffeina, colesterolo, emoglobina, creatinina, vitamina C, acido urico.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n Il test deve essere utilizzato secondo le istruzioni del produttore. In caso di risultato positivo, dubbio o contestato, si raccomanda una conferma tramite analisi di laboratorio.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDomande frequenti\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eDomande frequenti\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eDomande frequenti\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eCosa rileva il test urinario Drugdiag® 6?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Rileva 6 famiglie di sostanze nelle urine: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, \u003cstrong\u003ecocaina\u003c\/strong\u003e, \u003cstrong\u003eamfetamine\u003c\/strong\u003e, \u003cstrong\u003emetamfetamine\u003c\/strong\u003e, \u003cstrong\u003eoppioidi\u003c\/strong\u003e e \u003cstrong\u003ebuprenorfina\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003ePerché la buprenorfina è inclusa?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n La buprenorfina può essere ricercata in alcuni contesti medici o di dipendenza, in particolare durante il monitoraggio di trattamenti sostitutivi agli oppiacei.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eQuesto test è adatto per l’azienda?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Sì, può essere integrato in un percorso di prevenzione nei posti sensibili, nel rispetto del regolamento interno, della proporzionalità, della riservatezza e del quadro legale applicabile.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003ePer quanto tempo le droghe restano rilevabili nelle urine?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n La durata varia a seconda della sostanza e del profilo. Il THC-COOH può rimanere rilevabile più a lungo rispetto ad altre famiglie, talvolta fino a 30 giorni a seconda dei profili di consumo.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eUn risultato positivo ha valore definitivo?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n No. Un test rapido fornisce un risultato preliminare. Per ogni decisione ufficiale, disciplinare, medica o contestata, si raccomanda una conferma tramite metodo analitico di laboratorio.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-cta\"\u003e\n \u003cp\u003eHai bisogno di un consiglio o di un preventivo per un ordine professionale?\u003c\/p\u003e\n \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e\n Richiedi un preventivo\n \u003c\/a\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n \u003cp\u003e\n \u003cstrong\u003eAvvertenze legali :\u003c\/strong\u003e Questo dispositivo diagnostico \u003ci\u003ein vitro\u003c\/i\u003e è destinato a un uso professionale o personale, nel rispetto della legislazione francese ed europea vigente. Fornisce un risultato analitico preliminare. In contesti giudiziari, disciplinari, medici o contestati, ogni positività deve essere confermata da un’analisi di laboratorio.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"Confezione da 5","offer_id":56426433741124,"sku":"1046","price":59.5,"currency_code":"EUR","in_stock":true},{"title":"Confezione da 10","offer_id":56426433773892,"sku":"1046","price":113.05,"currency_code":"EUR","in_stock":true},{"title":"Confezione da 25","offer_id":56426433806660,"sku":"1046","price":252.88,"currency_code":"EUR","in_stock":true},{"title":"1 unità","offer_id":56426433708356,"sku":"1046","price":11.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Photo_produit_du_drugdiag_6.png?v=1777888318"},{"product_id":"test-urinaire-thc","title":"Test Urinario THC (Cannabis) Drugdiag®","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag THC urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e \u003cspan class=\"ama-bsafe-kicker\"\u003eTest urinario cannabis\u003c\/span\u003e \u003ch2 class=\"ama-bsafe-title\"\u003e Drugdiag® THC: test urinario cannabis THC-COOH a 50 ng\/mL \u003c\/h2\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Il \u003cstrong\u003etest urinario Drugdiag® THC\u003c\/strong\u003e è un dispositivo di screening professionale progettato per rilevare il \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, principale metabolita urinario della cannabis. A differenza del test salivare, che ricerca il THC attivo su un periodo breve, il test urinario consente di identificare un consumo più remoto. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Sviluppato da \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, laboratorio francese n.1 nei test diagnostici rapidi, questo test urinario cannabis offre una soglia di rilevamento calibrata a \u003cstrong\u003e50 ng\/mL\u003c\/strong\u003e. È adatto all’\u003cstrong\u003eauto-controllo\u003c\/strong\u003e, al \u003cstrong\u003erecupero patente\u003c\/strong\u003e, al \u003cstrong\u003emonitoraggio medico\u003c\/strong\u003e e alle attività di prevenzione aziendale. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Certificato \u003cstrong\u003eCE\u003c\/strong\u003e, conforme alla norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e e progettato per uso professionale, offre una lettura rapida, semplice e affidabile, con una correlazione superiore al \u003cstrong\u003e99 %\u003c\/strong\u003e con il metodo di riferimento \u003cstrong\u003eGC\/MS\u003c\/strong\u003e. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eRilevamento del THC-COOH urinario\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eSoglia standard: 50 ng\/mL\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eIdeale per recupero patente, azienda e monitoraggio\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eRilevamento\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eTHC-COOH urinario\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eSostanza rilevata\u003c\/h2\u003e \u003cp\u003e Il test urinario Drugdiag® THC ricerca il \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, principale metabolita della cannabis eliminato nelle urine. È adatto a situazioni in cui l’obiettivo è verificare un consumo passato o un’astinenza su un periodo più lungo rispetto alla saliva. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetabolita urinario della cannabis\u003c\/strong\u003e, derivato dalla degradazione del THC nell’organismo.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eFiori\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis classica\u003c\/strong\u003e, weed, marijuana, beuh.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eResina\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eHashish\u003c\/strong\u003e, polline, resina di cannabis.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eConcentrati\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOli, wax, rosin, e-liquid\u003c\/strong\u003e o prodotti concentrati contenenti cannabis.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eEdibles\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eProdotti alimentari infusi\u003c\/strong\u003e, dolci, caramelle o preparazioni contenenti cannabis.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCBD\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eProdotti CBD a spettro completo\u003c\/strong\u003e: un risultato positivo è possibile in caso di accumulo di THC residuo.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eRischio positivo\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e Questo test urinario non ricerca direttamente il Δ9-THC attivo nella saliva. Ricerca il \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, metabolita urinario della cannabis, che consente una finestra di rilevamento più lunga. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-alert\"\u003e \u003ch3\u003eAttenzione: CBD e risultato positivo\u003c\/h3\u003e \u003cp\u003e Il \u003cstrong\u003eCBD puro\u003c\/strong\u003e non è l’obiettivo del test. Tuttavia, alcuni prodotti CBD a spettro completo possono contenere tracce residue di THC. \u003c\/p\u003e \u003cp\u003e In caso di consumo regolare di fiori, resine o oli CBD contenenti THC residuo, il THC può accumularsi e poi essere eliminato nelle urine sotto forma di \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, con rischio di risultato positivo. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUtilizzi\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePatente, lavoro, monitoraggio\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eUtilizzi raccomandati\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eRecupero patente\u003c\/h3\u003e \u003cp\u003e Il test urinario Drugdiag® THC è particolarmente adatto all’auto-controllo prima di una visita medica, una commissione medica o un’analisi ufficiale. Aiuta a verificare se restano rilevabili tracce urinarie di cannabis. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eSicurezza sul lavoro\u003c\/h3\u003e \u003cp\u003e In azienda, può integrarsi in un percorso di prevenzione dei rischi su postazioni sensibili o di sicurezza, nel rispetto del regolamento interno, della riservatezza e del quadro applicabile, in particolare l’articolo \u003cstrong\u003eL.4121-1 del Codice del lavoro\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eMonitoraggio medico e prevenzione\u003c\/h3\u003e \u003cp\u003e Questo test può essere utilizzato nel contesto di un monitoraggio medico, di un supporto per la cessazione del consumo di cannabis o di un percorso di prevenzione individuale, con un risultato rapido e semplice da interpretare. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eVantaggi del test Drugdiag® THC\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eRilevamento urinario a lunga durata:\u003c\/strong\u003e ricerca del THC-COOH, metabolita persistente della cannabis.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSoglia standard:\u003c\/strong\u003e rilevamento calibrato a 50 ng\/mL.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUso versatile:\u003c\/strong\u003e recupero patente, auto-controllo, monitoraggio medico, azienda.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eLettura rapida:\u003c\/strong\u003e risultato visivo in pochi minuti secondo le istruzioni del produttore.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eProduttore francese:\u003c\/strong\u003e dispositivo della gamma Drugdiag® del laboratorio Toda Pharma.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQualità professionale:\u003c\/strong\u003e dispositivo medico diagnostico in vitro con marcatura CE e norma ISO 13485.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUtilizzato dalle Forze Armate Francesi:\u003c\/strong\u003e marchio UAF associato ai dispositivi della gamma Toda Pharma interessati.\u003c\/li\u003e \u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eRisultati\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eFinestre di rilevamento\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eFinestre di rilevamento urinario\u003c\/h2\u003e \u003cp\u003e A differenza del test salivare, che indica un consumo recente, il test urinario permette di identificare un consumo passato grazie al rilevamento del \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eOccasionale\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAssunzione unica o molto occasionale:\u003c\/strong\u003e durata del rilevamento indicativa generalmente compresa tra 1 e 3 giorni.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eIndicativo\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eRegolare\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003ePiù consumi a settimana:\u003c\/strong\u003e possibile rilevamento indicativo tra 5 e 12 giorni a seconda dei profili.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eVariabile\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCronico\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eUso quotidiano o intensivo :\u003c\/strong\u003e rilevamento possibile fino a 30 giorni, talvolta anche di più in alcuni soggetti.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eVariabile\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e I tempi di rilevamento sono indicativi. Variano in base al metabolismo, frequenza di consumo, concentrazione dei prodotti, BMI, idratazione e altri fattori individuali. \u003c\/p\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eRisultato negativo\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Un risultato negativo indica che il \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e non è stato rilevato oltre la soglia di 50 ng\/mL. Ciò non garantisce l’assenza assoluta di tracce, ma indica che la soglia del test non è stata superata. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eRisultato positivo\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Un risultato positivo indica una reazione compatibile con la presenza di \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e nelle urine. Per qualsiasi procedura ufficiale o contestata, si raccomanda una conferma con un metodo analitico di laboratorio. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eRisultato non valido\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Un risultato non valido può essere dovuto a una cattiva manipolazione, un volume insufficiente di campione o il mancato rispetto del tempo di lettura. In tal caso è necessario ripetere il test con un nuovo dispositivo. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTecnica\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eAffidabilità e qualità\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eCompetenza tecnica\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eTecnologia a oro colloidale\u003c\/h3\u003e \u003cp\u003e Il dispositivo utilizza l’immunocromatografia a competizione con anticorpi marcati con oro colloidale. Questa tecnologia consente una lettura visiva chiara, rapida e adatta agli usi professionali. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eAffidabilità GC\/MS\u003c\/h3\u003e \u003cp\u003e La precisione del test è stata confrontata con il metodo di riferimento di laboratorio, la cromatografia in fase gassosa accoppiata alla spettrometria di massa (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e), con una correlazione di accuratezza superiore al \u003cstrong\u003e99 %\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eConformità qualità\u003c\/h3\u003e \u003cp\u003e Progettato dal laboratorio francese Toda Pharma, questo dispositivo medico diagnostico \u003ci\u003ein vitro\u003c\/i\u003e è marcato \u003cstrong\u003eCE\u003c\/strong\u003e e conforme alla norma di qualità \u003cstrong\u003eISO 13485\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eCaratteristiche principali\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eTipo di test :\u003c\/strong\u003e test urinario cannabis a lettura rapida.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSostanza ricercata :\u003c\/strong\u003e THC-COOH, metabolita urinario della cannabis.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSoglia di rilevamento :\u003c\/strong\u003e 50 ng\/mL.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFormato :\u003c\/strong\u003e cassette urinaria confezionata singolarmente.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eConfezionamento :\u003c\/strong\u003e confezione singola sigillata con istruzioni in francese sulla confezione.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUso :\u003c\/strong\u003e prevenzione, auto-controllo, monitoraggio medico, recupero patente e azienda.\u003c\/li\u003e \u003c\/ul\u003e \u003ch3\u003eAssenza di reazioni crociate\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eFarmaci comuni :\u003c\/strong\u003e aspirina, ibuprofene, paracetamolo, amoxicillina, penicillina, destrometorfano.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSostanze fisiologiche e alimentari :\u003c\/strong\u003e caffeina, colesterolo, emoglobina, creatinina, vitamina C, acido urico.\u003c\/li\u003e \u003c\/ul\u003e \u003cp class=\"ama-bsafe-note\"\u003e Il test deve essere utilizzato secondo le istruzioni del produttore. In caso di risultato positivo, dubbio o contestato, la conferma tramite analisi di laboratorio rimane il riferimento. \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDomande frequenti\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eDomande frequenti\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eDomande frequenti\u003c\/h2\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eCosa rileva esattamente il test urinario Drugdiag® THC?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Rileva il \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, principale metabolita urinario della cannabis. Questo metabolita può rimanere rilevabile più a lungo rispetto al THC attivo ricercato nella saliva. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eQual è la differenza con un test salivare THC?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Il test salivare ricerca principalmente il THC attivo in una finestra temporale breve, spesso legata a un consumo recente. Il test urinario ricerca il THC-COOH, che può rimanere presente più a lungo nell’organismo. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eQuesto test è adatto per il recupero della patente?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Sì. È particolarmente utile per l’autocontrollo prima di una visita medica o di un’analisi ufficiale, poiché permette di verificare se il THC-COOH è ancora rilevabile nelle urine. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eIl CBD può rendere questo test positivo?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Sì, in alcuni casi. Il CBD puro non è l’obiettivo del test, ma prodotti a base di CBD contenenti tracce residue di THC possono causare positività, soprattutto in caso di consumo regolare. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003ePer quanto tempo la cannabis rimane rilevabile nelle urine?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e La durata dipende dal profilo di consumo. Può essere di circa 1-3 giorni per un uso occasionale, 5-12 giorni per un uso regolare, e fino a 30 giorni o più per alcuni consumatori cronici. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eUn risultato positivo ha valore legale definitivo?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e No. Un risultato positivo a un test rapido è un risultato preliminare. Per qualsiasi procedura ufficiale, è necessaria una conferma mediante metodo analitico di laboratorio. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-cta\"\u003e \u003cp\u003eHai bisogno di un consiglio o di un preventivo per un ordine professionale?\u003c\/p\u003e \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e Richiedi un preventivo \u003c\/a\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e \u003cp\u003e \u003cstrong\u003eAvvertenze legali :\u003c\/strong\u003e Questo test è un dispositivo diagnostico \u003ci\u003ein vitro\u003c\/i\u003e destinato a rilevare in modo indicativo la presenza di \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e nelle urine. Un risultato positivo preliminare indica la possibile presenza di metaboliti della cannabis ma non costituisce una prova legale definitiva. Si raccomanda una conferma mediante metodo analitico di laboratorio per qualsiasi procedura ufficiale. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"Confezione da 5","offer_id":56426433904964,"sku":"1041-THC","price":29.95,"currency_code":"EUR","in_stock":true},{"title":"Confezione da 10","offer_id":56426433937732,"sku":"1041-THC","price":56.91,"currency_code":"EUR","in_stock":true},{"title":"Confezione da 25","offer_id":56426433970500,"sku":"1041-THC","price":127.29,"currency_code":"EUR","in_stock":true},{"title":"1 unità","offer_id":56426433872196,"sku":"1041-THC","price":5.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Image_produit_Drgdiag_THC.png?v=1777887804"},{"product_id":"test-urinaire-cassette-11-drogues","title":"Test Urinario 11 Droghe Drugdiag® 11","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 11 urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e \u003cspan class=\"ama-bsafe-kicker\"\u003eTest urinario 11 droghe\u003c\/span\u003e \u003ch2 class=\"ama-bsafe-title\"\u003e Drugdiag® 11: test urinario multi-droga ad ampio spettro \u003c\/h2\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Il \u003cstrong\u003etest urinario Drugdiag® 11 droghe\u003c\/strong\u003e, sviluppato dal laboratorio francese \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, leader nei test diagnostici rapidi, consente la \u003cstrong\u003erilevazione simultanea di 11 famiglie di droghe\u003c\/strong\u003e nelle urine. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Ricerca in particolare il \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, le \u003cstrong\u003eamfetamine\u003c\/strong\u003e, i \u003cstrong\u003ebarbiturici\u003c\/strong\u003e, le \u003cstrong\u003ebenzodiazepine\u003c\/strong\u003e, la \u003cstrong\u003ebupenorfina\u003c\/strong\u003e, la \u003cstrong\u003ecocaina\u003c\/strong\u003e, la \u003cstrong\u003eMDMA\u003c\/strong\u003e, le \u003cstrong\u003emetanfetamine\u003c\/strong\u003e, gli \u003cstrong\u003eoppiacei\u003c\/strong\u003e, il \u003cstrong\u003emetadone\u003c\/strong\u003e e gli \u003cstrong\u003eantidepressivi triciclici\u003c\/strong\u003e. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Questo test multi-droga è particolarmente adatto per \u003cstrong\u003eaziende\u003c\/strong\u003e, \u003cstrong\u003emedici del lavoro\u003c\/strong\u003e, \u003cstrong\u003estrutture per le dipendenze\u003c\/strong\u003e, \u003cstrong\u003eprofessionisti della salute\u003c\/strong\u003e e organizzazioni che devono garantire la sicurezza in ambienti ad alta responsabilità. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eRilevamento simultaneo di 11 famiglie\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eFormato urinario a lettura rapida\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eUso aziendale, sanitario e in ambito delle dipendenze\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eRilevamento\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003e11 famiglie target\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eSostanze rilevate\u003c\/h2\u003e \u003cp\u003e Il test urinario Drugdiag® 11 consente una ricerca estesa delle principali famiglie di sostanze psicoattive, includendo sia le droghe più comuni, alcuni farmaci psicoattivi e molecole utilizzate nel monitoraggio delle dipendenze. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis:\u003c\/strong\u003e metabolita principale del THC, associato al consumo di cannabis, resina, fiori o prodotti contenenti THC.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAmfetamine:\u003c\/strong\u003e stimolanti di tipo amfetaminico, speed e sostanze correlate.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBAR\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBarbiturici:\u003c\/strong\u003e famiglia di depressori del sistema nervoso centrale.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepine:\u003c\/strong\u003e ansiolitici, ipnotici o sedativi che possono alterare la vigilanza.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBupenorfina:\u003c\/strong\u003e molecola utilizzata in particolare in alcuni trattamenti sostitutivi degli oppiacei.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e10 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaina:\u003c\/strong\u003e cocaina, crack e metaboliti correlati rilevabili nelle urine.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy:\u003c\/strong\u003e MDMA e sostanze correlate.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e500 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetamine:\u003c\/strong\u003e crystal meth, ice e derivati correlati.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOppiacei:\u003c\/strong\u003e morfina, eroina, oppio e composti correlati.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMTD\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetadone:\u003c\/strong\u003e molecola utilizzata in particolare in alcuni trattamenti sostitutivi degli oppiacei.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTCA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAntidepressivi triciclici:\u003c\/strong\u003e famiglia di farmaci psicoattivi ricercati in alcuni contesti clinici.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e Le soglie devono essere interpretate secondo il foglietto illustrativo del produttore, il contesto clinico o professionale e gli obiettivi dello screening. In caso di risultato positivo, potrebbe essere necessaria una conferma di laboratorio a seconda del contesto. \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUtilizzi\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eAzienda, salute, sicurezza\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePrincipali utilizzi\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003ePosizioni sensibili e settori a rischio\u003c\/h3\u003e \u003cp\u003e Il Drugdiag® 11 è particolarmente adatto per posizioni di sicurezza e protezione: trasporti, logistica, edilizia, industria pesante, manutenzione di impianti sensibili, energia, siti classificati o ambienti ad alto livello di responsabilità. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eFollow-up terapeutico e tossicologico\u003c\/h3\u003e \u003cp\u003e Grazie al rilevamento di \u003cstrong\u003emetadone\u003c\/strong\u003e, \u003cstrong\u003ebupenorfina\u003c\/strong\u003e e \u003cstrong\u003eTCA\u003c\/strong\u003e, questo test può essere utile a CSAPA, medici, psichiatri, cliniche e strutture di disintossicazione per documentare un follow-up, in complemento al colloquio clinico. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003ePrevenzione in azienda\u003c\/h3\u003e \u003cp\u003e Quando previsto da un regolamento interno, questo test può essere integrato in una procedura interna di prevenzione: controllo mirato, situazione a rischio, incidente, evento o percorso globale di sicurezza. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eAuto-controllo responsabile\u003c\/h3\u003e \u003cp\u003e Il Drugdiag® 11 può essere utilizzato anche da privati in un percorso di auto-controllo prima di una visita medica, un incontro professionale o una procedura amministrativa. Una conferma di laboratorio rimane necessaria in ogni contesto ufficiale. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eVantaggi del test Drugdiag® 11\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eRilevamento esteso:\u003c\/strong\u003e 11 famiglie di sostanze ricercate in un’unica analisi.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eStrumento versatile:\u003c\/strong\u003e aziende, medicina del lavoro, tossicologia, strutture medico-sociali, istituzioni e auto-controllo.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eLettura rapida:\u003c\/strong\u003e risultato visivo in pochi minuti secondo le istruzioni del produttore.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eProduttore francese:\u003c\/strong\u003e dispositivo della gamma Drugdiag® del laboratorio Toda Pharma.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQualità professionale:\u003c\/strong\u003e marcatura CE, sistema qualità ISO 13485 e tracciabilità dei lotti.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFollow-up tossicologico:\u003c\/strong\u003e pannelli BUP, MTD e TCA utili in alcuni contesti medici.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003ePolitica di prevenzione:\u003c\/strong\u003e integrabile in un percorso globale di informazione, formazione e accompagnamento.\u003c\/li\u003e \u003c\/ul\u003e \u003cdiv class=\"ama-bsafe-alert\"\u003e \u003ch3\u003eUso regolamentato in azienda\u003c\/h3\u003e \u003cp\u003e In ambito professionale, l’uso di test di screening deve essere previsto dal regolamento interno, giustificato dalla natura delle mansioni e attuato nel rispetto del Codice del lavoro, dei diritti dei lavoratori e della riservatezza. \u003c\/p\u003e \u003cp\u003e Il test Drugdiag® 11 si inserisce in una politica globale di prevenzione e non sostituisce mai la valutazione clinica né le analisi di conferma in laboratorio quando queste sono richieste. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eRisultati\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eDurate urinarie\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eDurate di rilevamento urinario\u003c\/h2\u003e \u003cp\u003e La durata di rilevamento delle sostanze nelle urine dipende da molti fattori: frequenza di consumo, quantità, metabolismo, stato di salute, funzione renale, idratazione, trattamento in corso e anzianità dell’uso. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis:\u003c\/strong\u003e durata indicativa molto variabile a seconda della frequenza e dell’intensità del consumo.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 30 giorni\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAmfetamine:\u003c\/strong\u003e durata indicativa generalmente compresa tra 1 e 4 giorni.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 giorni\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBAR\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBarbiturici :\u003c\/strong\u003e durata indicativa variabile secondo molecola, dose e uso.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 5 giorni\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepine :\u003c\/strong\u003e durata indicativa variabile, può essere più lunga in caso di trattamento prolungato.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 giorni+\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBupenorfina :\u003c\/strong\u003e durata indicativa variabile secondo dose, frequenza e durata del trattamento.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 giorni\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaina :\u003c\/strong\u003e durata indicativa generalmente compresa tra 1 e 4 giorni.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 giorni\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy :\u003c\/strong\u003e durata indicativa generalmente compresa tra 1 e 3 giorni.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 3 giorni\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetamine :\u003c\/strong\u003e durata indicativa generalmente compresa tra 1 e 4 giorni.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 giorni\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOppiacei :\u003c\/strong\u003e durata indicativa generalmente compresa tra 1 e 4 giorni.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 giorni\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMTD\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetadone :\u003c\/strong\u003e durata indicativa variabile secondo lo schema terapeutico.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 giorni\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTCA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAntidepressivi triciclici :\u003c\/strong\u003e durata indicativa variabile secondo la molecola e il dosaggio.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 giorni\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e Queste durate hanno un valore indicativo e non possono mai costituire una prova assoluta di consumo o astinenza. Devono essere interpretate secondo il contesto clinico, le dichiarazioni della persona e, se necessario, esami complementari. \u003c\/p\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eRisultato negativo\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Un risultato negativo indica che le famiglie ricercate non sono state rilevate oltre le soglie del test. Ciò non garantisce l’assenza assoluta di qualsiasi sostanza. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eRisultato positivo\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Un risultato positivo indica una reazione compatibile con la presenza di una o più famiglie ricercate nelle urine. Si raccomanda una conferma in laboratorio in ogni contesto ufficiale, medico, disciplinare o contestato. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eRisultato non valido\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Un risultato non valido può essere dovuto a una cattiva manipolazione, un volume insufficiente di campione o il mancato rispetto del tempo di lettura. In tal caso è necessario ripetere il test con un nuovo dispositivo. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTecnica\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQualità e affidabilità\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eCompetenza tecnica\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eTecnologia a oro colloidale\u003c\/h3\u003e \u003cp\u003e Il dispositivo utilizza l’immunocromatografia a competizione con anticorpi marcati con oro colloidale, permettendo una lettura chiara, rapida e adatta agli usi professionali. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eAffidabilità GC\/MS\u003c\/h3\u003e \u003cp\u003e La precisione di questo dispositivo di screening urinario professionale è stata confrontata con il metodo di riferimento di laboratorio, la cromatografia in fase gassosa accoppiata alla spettrometria di massa (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e). \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eConformità qualità\u003c\/h3\u003e \u003cp\u003e Progettato dal laboratorio francese Toda Pharma, questo dispositivo medico diagnostico \u003ci\u003ein vitro\u003c\/i\u003e è certificato \u003cstrong\u003eCE\u003c\/strong\u003e, con un sistema di qualità conforme alla norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e e completa tracciabilità dei lotti. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eCaratteristiche principali\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eTipo di test :\u003c\/strong\u003e test urinario multi-droga a lettura rapida.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSostanze ricercate :\u003c\/strong\u003e THC-COOH, AMP, BAR, BZO, BUP, COC, MDMA, MET, MOP, MTD, TCA.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFormato:\u003c\/strong\u003e test urinario semplice da usare con lettura visiva delle bande di risultato.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUso:\u003c\/strong\u003e prevenzione professionale, medicina del lavoro, dipendenze, monitoraggio terapeutico, auto-controllo.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eProduttore:\u003c\/strong\u003e laboratorio francese Toda Pharma, n°1 nel test diagnostico rapido.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQualità:\u003c\/strong\u003e dispositivo medico diagnostico in vitro con marcatura CE e ISO 13485.\u003c\/li\u003e \u003c\/ul\u003e \u003ch3\u003eAssenza di reazioni crociate\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eFarmaci comuni:\u003c\/strong\u003e aspirina, ibuprofene, paracetamolo, amoxicillina, penicillina, destrometorfano.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSostanze fisiologiche e alimentari:\u003c\/strong\u003e caffeina, colesterolo, emoglobina, creatinina, vitamina C, acido urico.\u003c\/li\u003e \u003c\/ul\u003e \u003cp class=\"ama-bsafe-note\"\u003e Il test deve essere utilizzato conformemente al foglio illustrativo del produttore. In caso di risultato positivo, dubbio o contestato, è sempre raccomandata una conferma tramite analisi di laboratorio. \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDomande frequenti\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eDomande frequenti\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eDomande frequenti\u003c\/h2\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eCosa rileva il test urinario Drugdiag® 11?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Rileva 11 famiglie di sostanze nelle urine: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, \u003cstrong\u003eAMP\u003c\/strong\u003e, \u003cstrong\u003eBAR\u003c\/strong\u003e, \u003cstrong\u003eBZO\u003c\/strong\u003e, \u003cstrong\u003eBUP\u003c\/strong\u003e, \u003cstrong\u003eCOC\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e, \u003cstrong\u003eMET\u003c\/strong\u003e, \u003cstrong\u003eMOP\u003c\/strong\u003e, \u003cstrong\u003eMTD\u003c\/strong\u003e e \u003cstrong\u003eTCA\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eA chi è rivolto questo test?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e È rivolto ad aziende, medici del lavoro, strutture di dipendenze, professionisti della salute, organizzazioni esposte a rischi di sicurezza e privati che desiderano effettuare un auto-controllo responsabile. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eQuesto test è adatto al monitoraggio delle dipendenze?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Sì. I pannelli \u003cstrong\u003eBUP\u003c\/strong\u003e, \u003cstrong\u003eMTD\u003c\/strong\u003e e \u003cstrong\u003eTCA\u003c\/strong\u003e, associati alle altre famiglie ricercate, possono essere utili in alcuni monitoraggi terapeutici o delle dipendenze, in complemento alla valutazione clinica. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003ePuò essere utilizzato in azienda?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Sì, se il suo utilizzo è previsto dal regolamento interno, giustificato dalla natura delle mansioni, proporzionato al rischio e attuato nel rispetto del Codice del lavoro, dei diritti dei lavoratori e della riservatezza. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eUn risultato positivo ha valore definitivo?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e No. Un test rapido fornisce un risultato analitico preliminare. In ogni contesto ufficiale, giudiziario, amministrativo, disciplinare, medico o contestato, è raccomandata una conferma tramite metodo analitico di laboratorio. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-cta\"\u003e \u003cp\u003eHai bisogno di un consiglio o di un preventivo per un ordine professionale?\u003c\/p\u003e \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e Richiedi un preventivo \u003c\/a\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e \u003cp\u003e \u003cstrong\u003eAvvertenze legali :\u003c\/strong\u003e Questo dispositivo medico diagnostico \u003ci\u003ein vitro\u003c\/i\u003e è destinato a un uso professionale e, se del caso, a un uso personale responsabile, nel rispetto della legislazione francese ed europea vigente. Fornisce un risultato analitico preliminare e non sostituisce un’analisi di conferma in laboratorio nell’ambito di una procedura giudiziaria, amministrativa, medica, disciplinare o contestata. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unità","offer_id":56426434199876,"sku":"10411","price":14.94,"currency_code":"EUR","in_stock":true},{"title":"Confezione da 5","offer_id":56426434232644,"sku":"10411","price":74.7,"currency_code":"EUR","in_stock":true},{"title":"Confezione da 10","offer_id":56426434265412,"sku":"10411","price":141.93,"currency_code":"EUR","in_stock":true},{"title":"Confezione da 25","offer_id":56426434298180,"sku":"10411","price":317.47,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Photo_Poduit_du_drugdiag_11.png?v=1777888364"}],"url":"https:\/\/ama-prevention.com\/it\/collections\/toda-drugdiag-cassette.oembed","provider":"AMA Prévention ","version":"1.0","type":"link"}